Skip to main
SBTX

Silverback Therapeutics (SBTX) Market Capitalization Overview

Market Cap: $933.14M as of Feb 19, 2026

$933.14M
$117.63M (11.19%)past month
As of Feb 19, 2026, Silverback Therapeutics (SBTX) has a market capitalization of $933.14M. Over the past 30 days, its market cap has decreased by -10.36%, while in the last 12 months, it has decreased by -18.97%.

Market capitalization represents the total value of Silverback Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Silverback Therapeutics (SBTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Silverback Therapeutics (SBTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Silverback Therapeutics (SBTX) Market Cap History

DateMarket CapChange
Dec 1, 2025$929.18M+9.07%
Nov 3, 2025$851.89M-14.57%
Oct 1, 2025$997.16M-9.26%
Sep 2, 2025$1.10B-34.87%
Aug 1, 2025$1.69B+6.77%
Jul 1, 2025$1.59B+11.27%
Jun 2, 2025$1.43B+2.22%
May 1, 2025$1.39B+13.01%
Apr 1, 2025$1.23B+24.27%
Mar 3, 2025$989.35M-17.30%
Feb 3, 2025$1.20B+14.94%
Jan 2, 2025$1.05B-19.59%

Silverback Therapeutics (SBTX) End of Year Market Cap History

DateMarket CapChange
2026$933.14M-18.97%
2025$1.16B+12.32%
2024$1.03B+94.90%
2023$526.07M+71.04%
2022$307.58M+31.66%
2021$233.61M

FAQs About Silverback Therapeutics (SBTX) Market Cap

As of Feb 19, 2026, the market capitalization of Silverback Therapeutics (SBTX) is $933.14M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Silverback Therapeutics’s market capitalization has decreased by -11.19%, changing from $1.06B to $933.14M as of Feb 19, 2026.

In the last 3 months, Silverback Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Silverback Therapeutics’s market capitalization increased from $1.03B in January to $1.16B in December, reflecting a 12.32% change.

In the past five years, Silverback Therapeutics (SBTX) has had a compound annual growth rate (CAGR) of 37.58% in market capitalization. This means its market cap has grown at an average rate of 37.58% per year.

Silverback Therapeutics (SBTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.